Cargando…

Reliability of CD44, CD24, and ALDH1A1 immunohistochemical staining: Pathologist assessment compared to quantitative image analysis

BACKGROUND: The data on the expression of stem cell markers CD44, CD24, and ALDH1A1 in the breast tissue of cancer-free women is very limited and no previous studies have explored the agreement between pathologist and computational assessments of these markers. We compared the immunohistochemical (I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yaghjyan, Lusine, Heng, Yujing J., Baker, Gabrielle M., Bret-Mounet, Vanessa, Murthy, Divya, Mahoney, Matt B., Mu, Yi, Rosner, Bernard, Tamimi, Rulla M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794585/ https://www.ncbi.nlm.nih.gov/pubmed/36590957 http://dx.doi.org/10.3389/fmed.2022.1040061

Ejemplares similares

Associations of alcohol consumption with breast tissue composition
por: Yaghjyan, Lusine, et al.
Publicado: (2023)

Associations of reproductive breast cancer risk factors with breast tissue composition
por: Yaghjyan, Lusine, et al.
Publicado: (2021)

Adolescent fiber intake and mammographic breast density in premenopausal women
por: Yaghjyan, Lusine, et al.
Publicado: (2016)

Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis
por: Hong, Injae, et al.
Publicado: (2015)

Associations of aspirin and other anti-inflammatory medications with breast cancer risk by the status of COX-2 expression
por: Yaghjyan, Lusine, et al.
Publicado: (2022)

Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells
por: Lin, Li, et al.
Publicado: (2013)

Immunohistochemical Expression of CD(56) and ALDH(1 )in Common Salivary Gland Tumors
por: Seifi, Safoura, et al.
Publicado: (2016)

Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2017)

CD44 Expression in Oral Lichen Planus and Related Lesions—An Immunohistochemical Study
por: Chandrasekar, Muthulakshmi, et al.
Publicado: (2023)

Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring
por: Rizzardi, Anthony E, et al.
Publicado: (2012)

The combination of aldehyde dehydrogenase 1 (ALDH1) and CD44 is associated with poor outcomes in endometrial cancer
por: Huang, Hsin-Hui, et al.
Publicado: (2018)

Author Correction: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2018)

Cancer stem cell markers ALDH1 and CD44+/CD24– phenotype and their prognosis impact in invasive ductal carcinoma
por: Rabinovich, Iris, et al.
Publicado: (2018)

Postmenopausal mammographic breast density and subsequent breast cancer risk according to selected tissue markers
por: Yaghjyan, Lusine, et al.
Publicado: (2015)

Immunohistochemical analysis of CD44s and CD44v6 in endometriosis and adenomyosis : comparison with normal, hyperplastic, and malignant endometrium.
por: Lin, Z., et al.
Publicado: (2001)

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
por: Lugli, A, et al.
Publicado: (2010)

Expression of Androgen Receptor and Cancer Stem Cell Markers (CD44(+)/CD24(−) and ALDH1(+)): Prognostic Implications in Invasive Breast Cancer()()
por: Riaz, Nazia, et al.
Publicado: (2018)

Prognostic Value of Cancer Stem Cell Markers CD44 and ALDH1/2 in Gastric Cancer Cases
por: Senel, Fatma, et al.
Publicado: (2017)

PanCD44 Immunohistochemical Evaluation in Prostatectomies from Patients with Adenocarcinoma
por: Hirth, Carlos Gustavo, et al.
Publicado: (2018)

Ber-H2 (CD30) Immunohistochemical Staining of Human Fetal Tissues
por: Tamiolakis, D, et al.
Publicado: (2005)

STAT3 as a potential therapeutic target in ALDH(+) and CD44(+)/CD24(+) stem cell-like pancreatic cancer cells
por: Lin, Li, et al.
Publicado: (2016)

ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas
por: Adams, April, et al.
Publicado: (2015)

Relationship Between Immunohistochemical CD3, CD4, CD5, CD8, and PD1 Staining and Histopathological Diagnosis of Cervical Lesions in Patients With Abnormal Colposcopic Findings
por: Atigan, Ayhan, et al.
Publicado: (2022)

Relationship between immunohistochemical staining extent of CD47 and histopathologic features of bladder tumor
por: Olcucuoglu, Erkan, et al.
Publicado: (2017)

Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.
por: Sliutz, G., et al.
Publicado: (1995)

Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases
por: Horimoto, Yoshiya, et al.
Publicado: (2016)

Immunohistochemistry scoring of breast tumor tissue microarrays: A comparison study across three software applications
por: Baker, Gabrielle M., et al.
Publicado: (2022)

Knockdown of ALDH1A3 reduces breast cancer stem cell marker CD44 via the miR-7-TGFBR2-Smad3-CD44 regulatory axis
por: Pan, Meng, et al.
Publicado: (2021)

CD34 and p53 Immunohistochemical Stains Differentiate Hypocellular Myelodysplastic Syndrome (hMDS) from Aplastic Anemia and a CD34 Immunohistochemical Stain Provides Useful Survival Information for hMDS
por: Cha, Choong-Hwan, et al.
Publicado: (2014)

CD44 Staining of Cancer Stem-Like Cells Is Influenced by Down-Regulation of CD44 Variant Isoforms and Up-Regulation of the Standard CD44 Isoform in the Population of Cells That Have Undergone Epithelial-to-Mesenchymal Transition
por: Biddle, Adrian, et al.
Publicado: (2013)

Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC
por: Jakob, Mark, et al.
Publicado: (2020)

Immunohistochemical Detection of Cancer Stem Cell Related Markers CD44 and CD133 in Metastatic Colorectal Cancer Patients
por: Pitule, Pavel, et al.
Publicado: (2014)

Lung cancer tumorigenicity and drug resistance are maintained through ALDH(hi)CD44(hi) tumor initiating cells
por: Liu, Jing, et al.
Publicado: (2013)

Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients
por: Strati, Areti, et al.
Publicado: (2019)

The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients
por: Izycka, Natalia, et al.
Publicado: (2023)

The Intraoperative Immunohistochemical Staining of CD56 and CK19 Improves Surgical Decision for Thyroid Follicular Lesions
por: Pyo, Ju Yeon, et al.
Publicado: (2017)

Cutaneous Syncytial Myoepithelioma with Positive CD34 Immunohistochemical Staining: An Unusual Tumor and a Challenging Diagnosis
por: Ariasi, Cesare, et al.
Publicado: (2023)

ALDH1+ stem cells demonstrate more stem cell-like characteristics than CD44(+)/CD24(–/low) stem cells in different molecular subtypes of breast cancer
por: Chen, Jie, et al.
Publicado: (2020)

Immunohistochemical expression of CD44s in human neuroblastic tumors: Moroccan experience and highlights on current data
por: Tabyaoui, Imane, et al.
Publicado: (2013)

Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer
por: Kong, Yanan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hnlq5rhbb3fojuefmetilaofap